Genetic Analysis of Invasive Pneumococcal Isolates from Children in Ontario, Canada, 2007-2012

Pediatric Infectious Disease Journal

Volumn 34, Issue 6, 2015, Pages 594-598

  Deng, Xianding ^a,b   Arya, Gitanjali ^b   Memari, Nader ^b   MacKenzie, Ronald ^a   Macmullin, Gregory ^a   Low, Donald E ^b,c   Pillai, Dylan R ^d   Gubbay, Jonathan B ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PUBLIC HEALTH ONTARIO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

clonal complex; MLST; Sequence type; serotype; Streptococcus pneumoniae

Indexed keywords

CEFTRIAXONE; CEFUROXIME; ERYTHROMYCIN; MEROPENEM; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CANADA; CHILD; FEMALE; GENE SWITCHING; GENETIC ANALYSIS; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; HOUSEKEEPING GENE; HUMAN; INFANT; MALE; MULTILOCUS SEQUENCE TYPING; NEWBORN; NONHUMAN; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; SEROTYPING; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; BACTEREMIA; CLASSIFICATION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; ONTARIO; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; ONTARIO; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84937690091     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000697     Document Type: Article

References (22)

1. O'Brien KL, Millar EV, Zell ER, Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 2007 196 1211 1220
2. Reinert R, Jacobs MR, Kaplan SL., Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine 2010 28 4249 4259
3. Rudnick W, Liu Z, Shigayeva A, Toronto Invasive Bacterial Diseases Network Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011. Vaccine 2013 31 5863 5871
4. Kellner JD, Vanderkooi OG, MacDonald J, Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 2009 49 205 212
5. Maiden MC, Bygraves JA, Feil E, Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998 95 3140 3145
6. Enright MC, Spratt BG., A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998 144 3049 3060
7. Bettinger JA, Scheifele DW, Kellner JD, Canadian Immunization Monitoring Program, Active (IMPACT) The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007. Vaccine 2010 28 2130 2136
8. Hicks LA, Harrison LH, Flannery B, Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007 196 1346 1354
9. Demczuk WH, Martin I, Griffith A, Toronto Invasive Bacterial Diseases Network; Canadian Public Health Laboratory Network Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010. Can J Microbiol 2012 58 1008 1017
10. Pilishvili T, Lexau C, Farley MM, Active Bacterial Core Surveillance/Emerging Infections Program Network Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010 201 32 41
11. Demczuk W, Griffith A, Singh R, Streptococcus quarterly report. Canadian network for public health intelligence. Available at: www.cnphi-rcrsp.ca. Accessed July 1, 2014
12. Kaplan SL, Barson WJ, Lin PL, Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2013 32 203 207
13. Beall BW, Gertz RE, Hulkower RL, Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J Infect Dis 2011 203 1360 1368
14. Brueggemann AB, Griffith DT, Meats E, Clonal relationship between invasive and carriage Streptococcus pneumoniae and serotype-an clone-specific difference in invasive disease potential. J Infect Dis 2003 187 785 96
15. Jefferies JM, Smith A, Clarke SC, Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching. J Clin Microbiol 2004 42 5681 5688
16. Pillai DR, Shahinas D, Buzina A, Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae. BMC Genomics 2009 10 642
17. Kellner JD, Scheifele D, Vanderkooi OG, Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with Streptococcus pneumoniae in children in Calgary, Canada. Pediatr Infect Dis J 2008 27 526 532
18. Gonzalez BE, Hulten KG, Lamberth L, U.S. Pediatric Multicenter Pneumococcal Surveillance Group Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 2006 25 301 305
19. Deng X, Church D, Vanderkooi OG, Streptococcus pneumoniae infection: a Canadian perspective. Expert Rev Anti Infect Ther 2013 11 781 791
20. Low DE, Azavedo JD, McGeer A., Streptococcus pneumonia resistance data: macrolide-resistance pneumococci 1993-2009. Canadian Bacterial Surveillance Network. Available at: http://microbiology.mtsinai.on.ca/data/sp/index.shtml. Accessed June 30, 2014.
21. Zhanel GG, Palatnick L, Nichol KA, Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002. Antimicrob Agents Chemother 2003 47 1867 1874
22. Baek JY, Ko KS, Kang CI, In vitro antibacterial activities of doripenem, imipenem, and meropenem against recent Streptococcus pneumoniae isolates. Diagn Microbiol Infect Dis 2011 71 297 300